Medicrea lands FDA win for LigaPass spinal implant
French device maker Medicrea touted FDA approval for its LigaPass spinal fixation system, which uses a rod and strap system to connect vertebrae without using pedicle screws or hooks.
Royer Biomedical wins FDA approval to launch human trials of AppliGel drug delivery
Royer Biomedical landed FDA approval to proceed with human testing of its AppliGel-G polymer drug-delivery system in management of diabetic foot ulcers.
Tissue Therapies set to land CE Mark for VitroGro this month
Australia’s Tissue Therapies (AXS:TIS) is on track to land CE Mark approval in the European Union by the end of June for its VitroGro synthetic biologic protein in use for wound healing and tissue regeneration.